Literature DB >> 15484701

Sporadic amyotrophic lateral sclerosis of long duration mimicking spinal progressive muscular atrophy exists: additional autopsy case with a clinical course of 19 years.

Kuniaki Tsuchiya1, Michio Sano, Hidetoshi Shiotsu, Haruhiko Akiyama, Sadakiyo Watabiki, Kazuhiro Taki, Hiromi Kondo, Imaharu Nakano, Kenji Ikeda.   

Abstract

This report concerns an autopsy case of sporadic amyotrophic lateral sclerosis (ALS) clinically diagnosed as having spinal progressive muscular atrophy (SPMA). The patient was a Japanese woman without hereditary burden. She developed muscle weakness in the distal part of the right upper extremity at age 52, followed by muscle weakness in the left upper extremity and lower extremities at age 54 and 64, respectively. At age 66 she could not walk, even with assistance. Fasciculation and atrophy of the tongue appeared at age 68, followed by dysphagia and dysarthria at age 70. She died of respiratory disturbance at age 71. During the clinical course, neurological examination revealed neither Babinski sign nor hyperreflexia. No respirator administration was performed throughout the clinical course. Neuropathological examination disclosed not only neuronal loss with gliosis in the hypoglossal nucleus and anterior horns of the spinal cord, but also loss of Betz cells and degeneration of the pyramidal tract. Based on these clinicopathological findings and a literature review of sporadic autopsy cases of ALS with long clinical course (10 years or more), including four cases without pyramidal signs, we believe that sporadic ALS of long clinical course mimicking SPMA exists.

Entities:  

Mesh:

Year:  2004        PMID: 15484701     DOI: 10.1111/j.1440-1789.2004.00546.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  5 in total

1.  Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy.

Authors:  Felix Geser; Beth Stein; Michael Partain; Lauren B Elman; Leo F McCluskey; Sharon X Xie; Vivianna M Van Deerlin; Linda K Kwong; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2011-01-12       Impact factor: 17.088

Review 2.  On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia.

Authors:  F Geser; D Prvulovic; L O'Dwyer; O Hardiman; P Bede; A L W Bokde; J Q Trojanowski; H Hampel
Journal:  Prog Neurobiol       Date:  2011-09-03       Impact factor: 11.685

3.  Transgenic rat model of neurodegeneration caused by mutation in the TDP gene.

Authors:  Hongxia Zhou; Cao Huang; Han Chen; Dian Wang; Carlisle P Landel; Pedro Yuxing Xia; Robert Bowser; Yong-Jian Liu; Xu Gang Xia
Journal:  PLoS Genet       Date:  2010-03-26       Impact factor: 5.917

4.  FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration.

Authors:  Cao Huang; Hongxia Zhou; Jianbin Tong; Han Chen; Yong-Jian Liu; Dian Wang; Xiaotao Wei; Xu-Gang Xia
Journal:  PLoS Genet       Date:  2011-03-03       Impact factor: 5.917

5.  TDP-43 potentiates alpha-synuclein toxicity to dopaminergic neurons in transgenic mice.

Authors:  Tian Tian; Cao Huang; Jianbin Tong; Ming Yang; Hongxia Zhou; Xu-Gang Xia
Journal:  Int J Biol Sci       Date:  2011-03-04       Impact factor: 6.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.